A Case of Cryptococcal Meningitis in Hiv positive patient in A tertiary care hospital in Kancheepurum district, Tamilnadu, India

Shanthi Banukumar, I Kannan


Cryptococcal meningitis has been reported in recent years as major life threatening opportunistic infection associated with HIV with a leading cause of mortality ranging from 7 – 15 % around the world & 6% in United States of America. Approximately 25 – 30 % overall mortality rate is encountered in patients suffering from Cyrptococcal meningitis. Among the survivors 40% have significant neurological disorders like loss of vision, decreased mental function, hydrocephalus, cranial nerve palsies with relapse occurring in 25% of cases. It frequently presents as subacute meningitis and is a sporadic infection that affects both immunosuppressed patients (50%) and nonimmunosuppressed patients. This is the first case of cryptococcal meningitis reported in our Hospital in a HIV positive patient reported in our area – Rathinamangalam – Kancheepuram district – during a span of 2 years case study 2013 to 2014.

Full Text:



Speed B, Dunt D. Clinical & host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis.1995; 21(1):28 – 36.

Jain N, Wicks BL , Keller Sm, Fu J, Kesadevall A, Jain P et al .Molecular epidemiology of Cryptococcus neoformans strains in India. J Clin Microbiol. 2005: 43(11): 5733- 5742.

Aberg JA, Powderly WG. Cryptococcosis. Adv Pharmacol 1997; 37: 215-51.

Sukroongreung S, Eampokalap B, Tansuphaswadikul S, Nilakul C, Tantimavanich.S. Recovery of Cryptococcus neoformans patients. Mycopathologia 1998;143(3) :131-134.

Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS – 100yrs after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8(4): 515-48.

Park B.J,Wannemuehler.K.A,Marstan B.J, Govender N, Pappas P.G, Chiller T.M, Estimation of the current global burden of cryptococcal meningitis among persons living with HIV /AIDS. AIDS. 2009; 23(4): 525- 530.

Van der Horst CM, Saag MS, Cloud GA, Hammil RJ, Grabill.R. Sobel JD.Treatment of Cryptococcal meningitis associated with AIDS. N Engl J Med 1997; 337(1): 15-21.

Abhilash KPP, Mitra S, Arul JJJ, Raj PM, Balajii V, Kannangai R, Thomas SA, Abraham OC. Changing paradigm of Cryptococcus meningitis: An eight year experience from a tertiary hospital in South India. Ind J Med Micro, 2015;33 (1) 25 – 29.

Perfect JR. Crptococcosis. Infect. Dis .Clin. North Am .1989 (1); 3:77 -102.

Kisenge PR, Howkins AT, Marvo V.P, Mchele JPD,SwaiNS, Muller A, Houpt ER. Low CD4 count plus coma predicts Cryptococcal Meningitis in Tanzania. BMC Infect Dis 2007; 7:39-43 doi: 10.1186/1471-2334-7-39.

Kumar S , Wanchu A, Chakrabarti A, Sharma A, Bambery P et al . Cryptococcal meningitis in HIV infected experience from a north Indian Tertiary care center. Neurol India 2008; 56(4): 444- 449.

Prasad KN, Agarwal J, Nag VL, Varma AK, Dixit AK, Ayyagari A. Cryptococcal infection in patient with clinically diagnosed meningitis in a tertiary care centre. Neurol India. 2003 Sep;51(3):364-6.


  • There are currently no refbacks.